CTIS.eu › Cities › Sweden › Orebro
Orebro
Sweden
129 total trials
60 recruiting
2024-511053-22-00
4
2020-05-04
Primary sclerosing cholangitis (PSC)
2024-517387-37-00
4
2019-12-12
Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49
2023-505934-86-00
6
2019-03-26
Obesity
2023-506857-40-00
5
2019-01-08
Prostate Cancer
2023-504917-54-00
5
2018-10-30
Biochemical recurrence after prostate cancer surgery
2024-518998-33-00
5
2025-07-23
Ulcerative Colitis
2024-510730-40-00
5
2024-12-12
Hidradenitis Suppurativa
2024-513539-25-00
4
2024-11-22
Type 2 Diabetes Mellitus
2023-508096-36-00
5
2024-10-30
atopic dermatitis
2024-512408-20-00
4
2024-08-27
Schizophrenia spectrum disorder (SSD)
2024-515271-35-00
10
2023-02-01
Allergisk Rinit
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
2023-508588-58-00
4
2022-10-25
Diabetes type 1
2023-505255-51-00
5
2022-08-08
Herpes Zoster
2023-508897-27-00
5
2022-04-28
Multiple Myeloma
2024-512453-25-00
6
2022-04-28
Rheumatoid arthritis
2023-509208-14-00
5
2021-09-28
MULTIPLE MYELOMA
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
2024-512844-40-00
6
2021-04-20
Infertility
2023-504945-30-00
5
2021-03-16
Primary or recurrent non-muscle invasive bladder cancer with intermedi
2022-500439-35-00
5
2021-02-11
treatment-naive chronic lymphocytic leukemia
2023-505936-37-00
6
2021-02-03
Urothelial cancer
2022-502887-19-00
5
2020-08-18
Diffuse Large B-Cell Lymphoma
2022-501102-35-00
5
2019-12-02
Early triple negative breast cancer
Showing 73–96 of 129 trials